These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17465728)

  • 1. Towards the discovery of novel T-type calcium channel blockers.
    Lory P; Chemin J
    Expert Opin Ther Targets; 2007 May; 11(5):717-22. PubMed ID: 17465728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of recombinant low-voltage activated calcium channels.
    Lacinová L
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):105-11. PubMed ID: 15078185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T-type calcium channels in epilepsy and pain.
    Nelson MT; Todorovic SM; Perez-Reyes E
    Curr Pharm Des; 2006; 12(18):2189-97. PubMed ID: 16787249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking calcium-channel isoforms to potential therapies.
    Belardetti F; Zamponi GW
    Curr Opin Investig Drugs; 2008 Jul; 9(7):707-15. PubMed ID: 18600576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide.
    Chemin J; Monteil A; Perez-Reyes E; Nargeot J; Lory P
    EMBO J; 2001 Dec; 20(24):7033-40. PubMed ID: 11742980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
    Hansen PB
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R227-37. PubMed ID: 25519728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low threshold T-type calcium channels as targets for novel epilepsy treatments.
    Powell KL; Cain SM; Snutch TP; O'Brien TJ
    Br J Clin Pharmacol; 2014 May; 77(5):729-39. PubMed ID: 23834404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.
    Zamponi GW; Striessnig J; Koschak A; Dolphin AC
    Pharmacol Rev; 2015 Oct; 67(4):821-70. PubMed ID: 26362469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-mediated inhibition of Cav3.2 T-type channels revisited.
    Perez-Reyes E
    Mol Pharmacol; 2010 Feb; 77(2):136-8. PubMed ID: 19903827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line.
    Chemin J; Nargeot J; Lory P
    J Neurosci; 2002 Aug; 22(16):6856-62. PubMed ID: 12177183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-type Ca2+ channels as therapeutic targets in the nervous system.
    Shin HS; Cheong EJ; Choi S; Lee J; Na HS
    Curr Opin Pharmacol; 2008 Feb; 8(1):33-41. PubMed ID: 18203662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and drug discovery for T-type calcium channels.
    McGivern JG
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):587-603. PubMed ID: 17168744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of neuronal T-type calcium channels.
    Lambert RC; Bessaih T; Leresche N
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):611-27. PubMed ID: 17168746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Ca2+ channels to treat pain: T-type versus N-type.
    Altier C; Zamponi GW
    Trends Pharmacol Sci; 2004 Sep; 25(9):465-70. PubMed ID: 15559248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-type calcium channels inhibitors: a patent review.
    Giordanetto F; Knerr L; Wållberg A
    Expert Opin Ther Pat; 2011 Jan; 21(1):85-101. PubMed ID: 21087200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 20. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
    Stamboulian S; Kim D; Shin HS; Ronjat M; De Waard M; Arnoult C
    J Cell Physiol; 2004 Jul; 200(1):116-24. PubMed ID: 15137064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.